🔍 See what insiders are buying — free 7-day trial, no credit card required.
Get started →
41Score
DipBuster Score™
$44.53
+$0.25 (+0.56%)
Live price · Source: Yahoo
52-Week Position
$35.12
32% of range
$64.16
Beta
0.349
Low vol
Dividend
—
no income
Mkt Cap
N/A
total value
Mkt CapN/A
P/EN/A
DividendNone
Beta0.349
52W High$64.16
52W Low$35.12
DipBuster Brief
Key signals at a glance
Zone: Buy Zone
Neutral
Mid-Range Position (32% of 52-Week Range)
The stock sits in the middle of its annual range — no extreme dip opportunity, but also not overextended.
Neutral
Earnings Data Unavailable
P/E ratio could not be determined — this is common for early-stage, loss-making, or recently-listed companies.
Valuation
P/E Ratio—
Mkt CapN/A
52W Position32% of range
EV/EBITDA—
Cash Flow
FCF Yield—
FCF / Share
Op. Cash Flow—
Margins
Gross Margin—
Op. Margin—
Net Margin—
Balance Sheet
Cash—
Total Debt—
Net Cash—
Dividend
Yield—
Annual / shNone
Beta0.349
🔒
FCF, margins & balance sheet data are hidden — create a free account to see them.
🕵️ Insiders
📊 Valuation
💰 Dividends
📰 News
🤖 AI Analysis
Loading insider data...
Valuation
P/E RatioN/A
Market CapN/A
Beta0.349
Dividend/yrNone
52W High$64.16
52W Low$35.12
52-Week Range
$35.12Now$64.16
32% through annual range
From 52W High−30.6%
From 52W Low+26.8%
📖 Plain English Summary
Novo Nordisk A/S is at 32% of its 52-week range. Beta 0.349 — tends to move less than the market.
🏦 Analyst Price Target
Loading…
🎯 Analyst Revenue & EPS Estimates
Loading estimates…
🔄 Peer Comparison
Loading peers…
Loading dividend data…
Latest news for NVO
🟢 Bullish
⬜ Neutral
🔴 Bearish
🤖
DipBuster AI Analysis — NVO
Heuristic · balance sheet, insider filings, price data, academic research
Novo Nordisk A/S — DipBuster Score 41/100
Graham value assessment, NCAV analysis, price zones...
Insider signals, cluster detection, risk factors...
Track Novo Nordisk A/S free
Add NVO to a watchlist, set insider-buy and price alerts, and get the full financial picture — free account, no card.
Sponsored · FCA Regulated Broker
Trading 212
Commission-free investing. ISA and GIA available. FCA regulated.
Free share worth up to £100 when you sign up
Capital at risk. Your investments can go down as well as up. Disclaimer
DipBuster Score™ Breakdown
Value & P/E
0/30
Dip Position
27/25
Momentum & Volume
9/25
Quality & Size
5/10
Insider Activity
0/10
🎯 Dip Buyer Signal
51
/100 · WATCH
dip depth
22/25
oversold rsi
14/25
mean reversion
15/15
insider zone
0/25
capitulation
0/10
Technical signal only. Not financial advice.
Quick Take
🟡
Watch
DipBuster Score: 41/100
📊
Run a full check in the AI analysis tab for a deeper look.
Company Profile
Novo Nordisk A/S is a global pharmaceutical firm dedicated to the investigation, creation, manufacturing, and distribution of medicinal products across a vast international footprint. Its market presence extends througho…
Sector
Pharmaceuticals
Market
🇺🇸 US
CEO
Maziar Mike Doustdar
Staff
68,794 employees
Website